Background
Peritoneal dialysis (PD) has been described as a simple and easily available method for the filtration of excess of water, electrolytes and metabolites.
Cozad et al. state that PD increases wellbeing, and allows more freedom, at personal level, than haemodialysis, because it implies less restrictive changes in lifestyle. It has also been argued that peritoneal dialysis should be offered to all appropriate patients suffering from endstage renal failure 1 
.
Infection prevention is considered essential for a successful maintenance of PD 2 . It is known that strategies to prevent or decrease infection risk include strict exit site care, catheter care, and particular attention when using an aseptic technique without contact to the exit site for dialysis interchanges. Apart from these strategies, there are other methods known to prevent infection, like reducing the biofilm in catheters, and treating nasal Staphylococcus aureus 3 . It has been documented that proper exit site care is essential for managing PD. There is evidence that exit site infections can penetrate the peritoneal space and cause peritonitis 4 . The abdominal tunnel through which the catheter travels, is a dark, wet, protected environment, thus the risk of tunnel infection, even when there is no peritonitis or exit site infection [5] [6] [7] . Both types of infection, at exit site and inside the tunnel, can cause peritonitis or failure of the PD therapy. A review of the literature proved that up to 20% of the patients treated with continuous ambulatory PD suffered from peritonitis due to catheter related causes, and that, in more than a fifth of the catheters removed, the reason for the removal could have been exit site infection 4 .
In 2003, Lockwood 8 et al. published a systematic review about the clinical effectiveness of the different approaches for exit site care of a PD catheter. The main focus of that review was to identify, evaluate and summarize existing research on methods for preventing exit site infection and care of PD catheters. A total of 131 articles, that studied a wide variety of interventions orientated to maintaining the exit site free of infection, were examined. These included: cleaning the area with potable tap water, antibiotic or antiseptic solution; using or avoiding dressings; and the use of antiseptic devices.
In this systematic review by Lockwood et al, few studies were found to be of sufficient quality to fulfil inclusion criteria. Outcome measures varied greatly, thus making it impossible to perform meta-analysis. Among its conclusions, this review suggests that topical mupirocin can reduce the risk of exit site infection. However, it did not establish clinical effectiveness of any antibiotic, antiseptic or procedure for exit site care, in the prevention or reduction of infection or peritonitis. This review has established gaps in the existing knowledge about exit site care of peritoneal catheters in patients with dialysis.
Current practice is variable and the optimal approach to exit site care is not known. Prowant's study 2 found that the most frequent interventions for exit site care were daily hygiene, the use of dressings to fix the catheter, and the use of cleaning agents. Some of the proposed methods of exit site care included cleaning with: In spite of the wide variety of studies presented relating to exit site care of the catheter, few were evaluated as rigorous. Clinical guidelines and published studies vary equally in terms of quality and description of how to develop a safe and successful exit site care. This variability seems to be in contradiction with the available list of primary studies.
Clinical effectiveness of exit site care of the PD catheter in reducing the risk of infection is a responsibility shared between patients and health professionals. IIn all forms of PD, patients manage their own self care during dialysis, with programmed visits to the health professionals for control, or for treatment, when there have been complications. Thus, the individual's willingness to adhere to exit site care is a significant feature of variability in practice, and potentially, also of the type and frequency of the treatment.
The primary interest of the review by Lockwood et al. was to evaluate interventions directly related to exit site care, as these could be cared for by health professionals or by patients within the home. Consequently, studies relating to the following were excluded from the review:
• types of catheters; • surgical insertion techniques; • systemic antibiotics; • nasal treatment of staphylococcus aureus colonisation.
The main implication for clinical practice of the systematic review by Lockwood et al. was that, at the time, it was not possible to recommend a procedure for exit site care, There are certain limitations to this systematic review that warrant an update, such as research literature limited to English language; the small number of databases searched; and the inclusion of only adult participants. The search strategy for article selection was limited to September 2002, and there have been five years since the publication of the review, more than enough time in knowledge management to recommend its update and to identify and incorporate new evidence. This may include new techniques for dialysis treatment that have been developed since the initial review, such as continuous cycle peritoneal dialysis, which could influence exit site care and that were not taken into account in the original review, and the new studies that suggest that applying antiseptic on the exit site could be effective against infection [9] [10] [11] . We propose using Lockwood's et al. systematic review as a basis for updating, evaluating and summarizing the best available evidence about this subject.
AIMS
The main aim of this review is to evaluate and summarise the best available evidence about peritoneal catheter exit site care to minimise the risk of infection.
The specific review questions to be addressed are:
• What is the most effective approach to managing peritoneal catheter exit sites during the initial post-operative period? • What is the most effective approach to the long term management of peritoneal catheter exit sites?
Inclusion Criteria

Types of studies
This systematic review will consider studies any randomised controlled trials (RCT) that evaluate the effectiveness of peritoneal dialysis catheter exit-site care. In the absence of any RCT's, other research designs such as non-randomised controlled trials, and before and after studies, will be considered for inclusion in a narrative summary to enable the identification of current approaches and possible future strategies.
Types of participants
Participants of interests are both adults and children (under 18) with chronic renal failure on maintenance peritoneal dialysis. Studies which analyse diabetic patients separately will be considered for inclusion as a subgroup analysis.
Types of interventions
Interventions of interest are those used to manage peritoneal catheter exit sites, both in the early post-operative period (from 0 to 14 days post insertion of the catheter), and the long term period (15 or more days post insertion). Interventions of interest include:
• Dressing of exit sites, including type of dressing, frequency of dressing and technique (aseptic vs. clean) • Exit site skin care, frequency and type of skin care (or product used).
• Education of the person with a peritoneal catheter, or a carer, on exit site management.
• Prophylactic treatments involving topic antimicrobial agents or antiseptic and devices.
Types of outcome measures
The outcomes of interest are those related to the effectiveness of peritoneal catheter exit site care. These outcomes will include incidence of exit site infection and peritonitis.
Outcome measures:
• Incidence of tunnel or exit site infection: Number of patients with infection inside the tunnel or at the exit site. Infection can be defined as the presence of redness, inflammation, exuberant granulation tissue and purulent/bloody exudate associated with erythema and oedema.
• Incidence of peritonitis: two positive (post dialysis cell count > 100 cells/ mm³ with >50% of polimorfonuclear leukocytes), peritoneal liquid cultures in an asymptomatic PD catheter carrier or a single positive in a PD catheter carrier with symptoms of peritonitis (such as abdominal pain, fever and cloudy peritoneal liquid).
• Reappearance of the peritonitis (after two to four weeks, due to the same microorganism).
• Lapse of time to the first episode of peritonitis.
• PD Catheter removal.
• Readmission rates related to peritonitis.
• Failure of the procedure (transfer from PD to haemodialysis).
• Death caused by peritonitis.
Search strategy for identification of studies
The first step will be to dump the quotes of the original review in a bibliographical quotes management system in order to:
• Adapt the keywords to the ones that appear in the papers that met the inclusion criteria in the first systematic review.
• Have the possibility to identify, at a later stage, articles that were not included, even though they met the criteria.
• Classify the literature published since the original review.
• Avoid duplication when using different combinations of keywords and databases.
A Sensitive search will be undertaken for each database in the COCHRANE LIBRARY (Cochrane Central Register of Controlled Trials, COCHRANE DATABASE OF SYSTEMATIC REVIEWS), MEDLINE, EMBASE, CINAHL, CURRENT CONTENTS, COCHRANE LIBRARY, PUBMED, EXPANDED ACADEMIC INDEX, (from September 2002 to the most recently available month).
Further searches, with no time limit, will be undertaken in the following databases: CUIDEN, Science Citation Index (ISI WEB OF KNOWLEDGE), IME, BIREME.
The searches will include the following languages: English, French, Spanish and Portuguese.
Search terms definition and search combinations:
• For selecting relevant articles about the main topic: The following databases will be used in the search of grey literature: 
EXPANDED ACADEMIC INDEX
The authors of studies potentially suitable for inclusion will be contacted for further explanations about data and methodological details, and to request any additional studies they might have, either published or not.
Studies presented in congresses and nephrology conferences, as well as guides and diffusion documents from scientific societies, will also be included, if experts consider them relevant to this systematic review.
The proceedings books of the following conferences will also used: 
Methods of the review Critical Appraisal
All identified studies that meet the inclusion criteria will be assessed by two independent reviewers for methodological validity, using the JBI's RCT Critical Appraisal Form (see Appendix I). If consensus cannot be achieved, assessment by a third reviewer will be undertaken.
Critical appraisal of studies will focus on selection, observation and information biases.
Data Collection
In order to minimise the risk of error during the transcription of data, data will be collected using the JBI's Data Extraction Form for RCT (Appendix II). The data to be collected will include:
• Demographical data about the study population 
Data synthesis
Comparability of studies will be in terms of the specific study population, intervention and outcome measures. When two or more comparable RCTs are identified, the results will be pooled in a meta-analysis to determine the effectiveness of the intervention.
Heterogeneity between comparable studies will be assessed using Chi Square. Heterogeneity will be considered when p-value is less than 0.05. I 2 will also be estimated to compare the different meta-analyses, where 0% indicates no observed heterogeneity, and 25%, 50% and 75% indicate low, moderate and high heterogeneity 12 . Double data entry, of at least 10% of the data, will be utilised to minimise the risk of error during the data entry phase of the analysis.
Corresponding measures of effect will be calculated using Odds Ratio (for dichotomous variables data) or the weighted mean difference (for continuous variables). The 95% confidence interval will be calculated for all studies.
A subgroup analysis will be undertaken, after excluding the largest study, to determine its effect on the results. The subgroup analysis will be undertaken according to age group (18 years or younger, older than 18) and patient type (diabetic, non diabetic).
Where statistical pooling is not appropriate, or possible, the results will be summarised in narrative form. JBI SUMARI will be used for data synthesis (meta-analysis). 
